← Back to headlines
SynbioTech to Present TWK10� Research and Microbiome CDMO Platform in the Emerging GLP-1 Companion-Nutrition Market at Vitafoods Asia 2026
As GLP-1-based therapies reshape weight management, brands are looking beyond appetite control to nutrition quality, ...
1 Sept, 03:50 — 1 Sept, 03:50
Related Stories
Croatia Launches Mosquito Control Operations After West Nile Virus Cases
57m ago
Novartis Halts Autoimmune Cell Therapy Trials After Patient Deaths
1h ago
Spain Records Over 5,000 Heat-Related Deaths During Unprecedented Summer
3h ago
Singer Lionel Richie Hospitalized in ICU Following Concert Medical Episode
3h ago